C3 Polymorphism and circulating immune complexes in patients with multiple sclerosis
2009; Wiley; Volume: 62; Issue: 4 Linguagem: Inglês
10.1111/j.1600-0404.1980.tb03030.x
ISSN1600-0404
Autores Tópico(s)Amyloidosis: Diagnosis, Treatment, Outcomes
ResumoThe phenotypes of the complement factor C3 have been evaluated in 60 patients with multiple sclerosis (M.S.), and the results correlated to the occurrence of circulating immune complexes (CIC). A significantly increased frequency of the C3F-gene was found among the patients, and closely associated with the occurrence of CIC. A relative risk incidence of 4.1 was found for C3F-positive individuals among M.S. patients with detectable CIC. Low C3 levels in serum were found in 30% of the patients, almost all belonged to the group without CIC and showed a C3-type distribution similar to normal controls. A different immunological reaction pattern (type II reaction) in these patients seems possible, and a genetically determined immunological abnormality predisposing to M.S. is therefore suggested.
Referência(s)